Summary There has been an average annual decline in detection rates of all types ofleprosy in Malawi of around 11· 6% between 1977 and 1991. There was no obvious acceleration or slowing down of this decline fo llowing the introduction of WHO/MDT in 1983-84. Disability ratios stayed at the same level of about 11% during the 15 years covered by this paper suggesting that patients did not self report earlier after 1983-84 which might have masked an underlying accelerated decline in detection rates. Thus it is concluded that the influence of WHO/MDT on the pattern of leprosy over a period of time, in a country like Malawi, is so far not noticeably different from any influence dapsone monotherapy might have had.
It is now well known that shortening anti-leprosy treatment--e.g. by implementing the WHO recommended multi-drug-therapy (WHO/MDT) ! markedly decreases the number of patients on treatment (prevalence rates). 2 .3.4 Expectations that multi-drug-treatment would break chains of transmission fa ster than dapsone monotherapy and thus lead to a noticeable decline (or an acceleration in the decline) of incidence rates have so fa r not been fu lfilled.5•6•7 On the other hand, there are detection rate data which have been interpreted to show such an effect. 8 Leprosy control activities in Malawi have been intensified since 1966 with the assistance of the British Leprosy Relief Association (LEPRA). Given the continuity of main operational methods (e.g. passive case finding and mobile treatment) at least since 1973,9 we feel that a description of detection rates in Malawi covering the period before and after the introduction of WHO/MDT in 1983/84 is a useful contribution to the ongoing discussion on the influence of multi-drug-treatment on the patterns of leprosy over time.1o Because detection activities in Malawi were constant over time, trends in detection rates can be assumed to reflect trends in incidence rates.
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Methods
Methods of leprosy control work in Malawi up to 1983 have been described in detail in a previous pUblication.9 WHO/MDT was introduced in the whole country between April 1983 and December 1984. The procedure adopted was to review patients on treatment at that time and to release those fr om treatment who (i) had paucibacillary leprosy (PB), had been treated for at least 4 years and whose lesions were inactive at the time of review or (ii) had multi bacillary leprosy (MB), had been treated for at least 5 years and whose slit skin smears had been negative for at least 5 years. All other patients were given WHO/MDT: 6 monthly doses for PB leprosy Clnd \lntil smear negativity for MB leprosy (but for not less than 2 years during which period the patient had to take at least eighteen monthly doses). This review procedure led to a great reduction in the prevalence rate ofJ�prosy. The cadre of staff called clinic attendants was therefore made redundant. As a consequence anti leprosy treatment was from then on given on a monthly basis by leprosy control assistants (LeAs) rather than on a weekly basis by clinic attendants. All LeAs were equipped with motorcycles an,d great efforts were made to keep them mobile at all times. In general, as before, there wa� one LeA in each administrative district in Malawi but larger districts continued to have two LeAs. They continued to be �upervised by assistant field officers, field officers and medical officers.
Until 1982 the taking of slit skin smears had been prompted by a clinical suspicion, of MB leprosy but with the introduction of WHO/MDT slit skin smears were taken from (lll newly registered patients. Further new operational developments which added to the workload of LeAs were (i) the introduction of active surveillance after cOlll pletion of treatment of PB leprosy patients and (ii) the intensification of care for all patients who were left with disabilities after compl\etion of treatment.
In parallel with the introduction of WHO/MDT a computerized National Register 1980 1981 1982 1983 198� 1985 1986 1987 198!3 19�� 1990 1991 on 31st D!!cember of Year All new patients registered for anti-leprosy treatment and thought to be Malawian citizens are included in the data presented. Care was taken to exclude fo reigners (e.g. Mozambican refugees) from the calculations.
For the purpose of this paper a patient is considered to have a disability if according to the 1960 WHO disability grading systeml3 there was at least one score of 2 or higher at registration.
A multibacillary patient was, until 1982, defined as anyone registered as a new BB, BL or LL case with a positive slit skin smear result (BJ > 0) or else as a new LL case with no slit skin smear result but clinical findings typical for lepromatous leprosy. From 1983 Does WHO-MD T influence trends in leprosy incidence? onwards a MB patient is defined as any patient with a slit skin smear result of a BI of 2 or higher. In our experience these two definitions of MB leprosy are virtually the same.
Results Figure 1 and Table 1 show prevalence rates of leprosy in Malawi from 1980 until 1991. Prevalence rates declined most steeply during the years 1983 and 1984 when WHO/MDT was introduced. At the end of 1991 the prevalence rate had been reduced to 1438 patients on treatment per 9, 1 04,600 people (I, 58 per 10,000). Detection rates per 10,000 population from 1977 until 1991 are shown in Figure 2a and Table 2 . The rate fe ll from 4·7 per 10,000 in 1977 to 0·7 per 10,000 in 1991. This represents an average annual reduction (geometric mean of the decline) of 1 1·6%. Table 2 also shows (in percentage) the variation in the detection rates per year. The annual 'reduction' varies from an increase of 2·4% from 1986 to 1987 to a reduction of 21·2% from 1990 to 1991. Figure 2b shows detection rates after logarithmic transformation and, as expected fr om Figure 2a , demonstrates a log-linear relationship between years of detection and detection rates. There is no change in the trend (decline) of detection rates at any time after introduction of WHO/MDT. Figure 3 and Table 3 show multi bacillary ratios fr om 1977 to 1991. From 1977 to 1982 these ratios are based on the patients in those parts of the country which were used in an analysis of the epidemiology of leprosy in Malawi in a previous paper.14 From 1983 onwards ratios are based on all newly registered patients in Malawi. A doubling of the multi bacillary ratio fr om about 10% to 20% can be observed between 1977 and 1985. From then onwards the muItibacillary ratio appears to have remained constant. Disability ratios among newly registered patients are presented in Table 4 . This ratio of patients with any disability score greater than one varies between 9% and 13% per year without any apparent unde r lying trend. 
Discussion
We have shown in this paper that the average annual decline in detection rates of all types of leprosy in Malawi has been around 12·5% · since 1977 (Figures 2a, 2b and Table 2 ) and that there was no obvious acceleration or slowing down of this decline in the wake of introducing WHO/MDT in 1983-84. These data argue against WHO/MDT exerting any influence on the patterns of leprosy over time, in a country like Malawi, other than the influence dapsone monotherapy might have had. This argument is only valid in so far as operational methods and characteristics of patients remained the same after the introduction of WHO/MDT. Concerning opera tional methods we mentioned that the number of staff (and thus opportunities for new leprosy patients to self-report) were reduced fo llowing the dramatic decline of prevalence rates by 1985. However, this operational change, if it mattered, could only have resulted in an accelerated decline of detection rates-which is not seen. The operational change could not have masked an underlying genuine acceleration in decline and the reduction in staff therefore appears to be irrelevant for the point in question.
Concerning characteristics of patients we have shown that disability ratios remained constant between 1977 and 1991 and that there was no noticeable change at any time after 1983-84 (Table 4) . This supports the suggestion that the introduction of WHO/MDT did not result in earlier self-reporting which again could have masked an underlying genuine acceleration in the decline of detection rates. (Nor did the introduction of WHO/MDT result in higher disability ratios because of later self-reporting which could have been the effect of the reduction of staff.)
As a fu rther characteristic of patients we describe the multibacillary ratios among newly registered patients ( Figure 3, Table 3 ). It appears that the rise in multi bacillary ratios came to an end after the introduction of WHO/MDT and has remained constant since 1985. However, this variable is more difficult to interpret than the disability ratios because there were both a slight change in the definition in 1983 and a change of practice which we have mentioned. In addition, it could be argued that control services including slit skin smear services improved during the Seventies and early Eighties and that the rise in the multibacillary ratio resulted fr om this general improvement of quality. Thus there are three alternative explanations for the pattern of multi bacillary ratios shown: (i) the rise in the multi bacillary ratio until 1985 was merely due to operational circumstances or (ii) the rise was an indicator of the end phase of an epidemicls which declined no fu rther in the late Eighties or (iii) the introduction of WHO/MDT led to earlier case finding which caused a break in the rise of the multibacillary ratio. The third possible explanation is not supported by the patterns of detection rates and disability ratios. It therefore seems likely that operational circumstances and a declining epidemic shaped the pattern of multi bacillary ratios shown rather than the introduction of WHO/MDT. On the whole we therefore conclude on the basis of the experience in Malawi that a variety of factors (e.g. BCG vaccination,1 6,17 socioeconomic changes, leprosy control efforts) led to a steady reduction in detection rates of leprosy (and a parallel trend in incidence rates) in the late Seventies and throughout the Eighties and that this decline has not been accelerated by WHO/MDT so fa r.
